(Q26777441)

inferred from title

Hathewaya histolytica

object named as

clostridium histolyticum

1 reference

1

0 references

Andrew Elders

object named as

Andrew Elders

6

0 references

author name string

Moira Cruickshank

2

0 references

Emma Tassie

3

0 references

Paul McNamee

4

0 references

Clare Robertson

5

0 references

Cynthia Fraser

7

0 references

Rodolfo Hernandez

8

0 references

David Lawrie

9

0 references

Craig Ramsay

Health Technology Assessment

10

0 references

language of work or name

English

0 references

publication date

October 2015

0 references

published in

0 references

volume

19

0 references

issue

90

0 references

page(s)

1-202

0 references

cites work

Determining clinically important changes in range of motion in patients with Dupuytren's Contracture: secondary analysis of the randomized, double-blind, placebo-controlled CORD I study

1 reference

7 January 2021

Gender ratio of Dupuytren's disease in the modern U.S. population

1 reference

7 January 2021

Epidemiological evaluation of Dupuytren's disease incidence and prevalence rates in relation to etiology

1 reference

7 January 2021

A systematic review of outcomes of fasciotomy, aponeurotomy, and collagenase treatments for Dupuytren's contracture

1 reference

7 January 2021

Percutaneous fasciotomy for the treatment of Dupuytren's disease-a systematic review

1 reference

7 January 2021

Examining the efficacy and maintenance of contracture correction after collagenase clostridium histolyticum treatment for Dupuytren's disease

1 reference

7 January 2021

Functional outcome of collagenase injections compared with fasciectomy in treatment of Dupuytren's contracture

1 reference

7 January 2021

Psychometric properties of health-related quality of life instruments in patients undergoing palmar fasciectomy for dupuytren's disease: a prospective study.

1 reference

7 January 2021

Early results of the use of collagenase in the treatment of Dupuytren's contracture.

1 reference

7 January 2021

Current trends in the surgical management of Dupuytren's disease in Europe: an analysis of patient charts

1 reference

7 January 2021

Isolated and spontaneous correction of proximal interphalangeal joint contractures in Dupuytren's disease: an exploratory analysis of the efficacy and safety of collagenase Clostridium histolyticum.

1 reference

7 January 2021

Fasciotomy and Z-plasty in the management of Dupuytren's contracture

1 reference

7 January 2021

Dupuytren's disease--a study of the pattern of distribution and stage of contracture in the hand

1 reference

7 January 2021

A study of the repeatability of the diagnosis of Dupuytren's contracture and its prevalence in the grampian region

1 reference

7 January 2021

The consequences of different definitions for recurrence of Dupuytren's disease

1 reference

7 January 2021

Collagenase injections for treatment of Dupuytren disease

1 reference

7 January 2021

Needle aponeurotomy for the treatment of Dupuytren's disease.

1 reference

7 January 2021

A prospective study linked both alcohol and tobacco to Dupuytren's disease

1 reference

7 January 2021

A comparison of the direct outcomes of percutaneous needle fasciotomy and limited fasciectomy for Dupuytren's disease: a 6-week follow-up study

1 reference

7 January 2021

Efficacy and safety of injectable mixed collagenase subtypes in the treatment of Dupuytren's contracture

1 reference

7 January 2021

Collagenase Injection as Nonsurgical Treatment of Dupuytren's Disease: 8-Year Follow-Up

1 reference

7 January 2021

Injectable collagenase Clostridium histolyticum: a new nonsurgical treatment for Dupuytren's disease.

1 reference

7 January 2021

Cost-effectiveness of open partial fasciectomy, needle aponeurotomy, and collagenase injection for dupuytren contracture.

1 reference

7 January 2021

Dupuytren contracture recurrence following treatment with collagenase clostridium histolyticum (CORDLESS study): 3-year data.

1 reference

7 January 2021

Efficacy and safety of collagenase clostridium histolyticum injection for Dupuytren contracture: short-term results from 2 open-label studies

1 reference

7 January 2021

The effect of a therapy protocol for increasing correction of severely contracted proximal interphalangeal joints caused by dupuytren disease and treated with collagenase injection.

1 reference

7 January 2021

The impact of Dupuytren disease on patient activity and quality of life.

1 reference

7 January 2021

A comparison of percutaneous needle fasciotomy and collagenase injection for dupuytren disease

1 reference

7 January 2021

Collagenase clostridium histolyticum for dupuytren contracture: patterns of use and effectiveness in clinical practice

1 reference

7 January 2021

Efficacy and safety of concurrent collagenase clostridium histolyticum injections for multiple Dupuytren contractures.

1 reference

7 January 2021

Severe contracture of the proximal interphalangeal joint in Dupuytren's disease: does capsuloligamentous release improve outcome?

1 reference

7 January 2021

Recurrence after surgery for Dupuytren's disease: a randomized trial of two skin incisions

1 reference

7 January 2021

Dupuytren's contracture: an audit of the outcomes of surgery.

1 reference

7 January 2021

Evaluation of activity limitation and digital extension in Dupuytren's contracture three months after fasciectomy and hand therapy interventions

1 reference

7 January 2021

Treatment of Dupuytren's disease using collagenase from Clostridium histolyticum

1 reference

7 January 2021

Advances in the understanding of the aetiology of Dupuytren's disease

1 reference

7 January 2021

1 reference

7 January 2021

Guillaume Dupuytren and finger contractures

1 reference

7 January 2021

Skin Tension in the Aetiology of Dupuytren’s Disease; a Prospective Trial

1 reference

7 January 2021

Assessment of percutaneous fasciotomy in the management of Dupuytren's contracture

1 reference

7 January 2021

Skin replacement in Dupuytren's disease

1 reference

7 January 2021

A mid-term review of the results of dermofasciectomy for Dupuytren's disease

1 reference

7 January 2021

1 reference

7 January 2021

Limited proteolysis of type I collagen at hyperreactive sites by class I and II Clostridium histolyticum collagenases: complementary digestion patterns

1 reference

7 January 2021

Scientific understanding and clinical management of Dupuytren disease.

1 reference

7 January 2021

Enzyme injection as nonsurgical treatment of Dupuytren's disease

1 reference

7 January 2021

Results following surgery for recurrent Dupuytren's disease

1 reference

7 January 2021

Collagen as a clinical target: nonoperative treatment of Dupuytren's disease

1 reference

7 January 2021

Functional benefit of Dupuytren's surgery

1 reference

7 January 2021

Injectable collagenase clostridium histolyticum for Dupuytren's contracture

1 reference

7 January 2021

Wnt signaling and Dupuytren's disease

1 reference

7 January 2021

Limited fasciectomy for Dupuytren's contracture

1 reference

7 January 2021

Patterns of the diseased fascia in the fingers in Dupuytren's contracture. Displacement of the neurovascular bundle

1 reference

7 January 2021

The surgical treatment of Dupuytren's contracture: a synthesis of techniques

1 reference

7 January 2021

Dupuytren's disease: history, diagnosis, and treatment

1 reference

7 January 2021

An evidence-based approach to Dupuytren's contracture

1 reference

7 January 2021

Five-year results of a randomized clinical trial on treatment in Dupuytren's disease: percutaneous needle fasciotomy versus limited fasciectomy

1 reference

7 January 2021

Dupuytren's contracture: an analysis of outcomes of percutaneous needle fasciotomy versus open fasciectomy.

1 reference

7 January 2021

Dupuytren's disease presentation, referral pathways and resource utilisation in Europe: regional analysis of a surgeon survey and patient chart review

1 reference

7 January 2021

Surgical management of Dupuytren's contracture in Europe: regional analysis of a surgeon survey and patient chart review

1 reference

7 January 2021

Mapping of an autosomal dominant gene for Dupuytren's contracture to chromosome 16q in a Swedish family

1 reference

7 January 2021

Dupuytren's contracture unfolded.

1 reference

7 January 2021

The GATE frame: critical appraisal with pictures

1 reference

7 January 2021

The feasibility of creating a checklist for the assessment of the methodological quality both of randomised and non-randomised studies of health care interventions

1 reference

7 January 2021

Heavy manual work, exposure to vibration and Dupuytren's disease? Results of a surveillance program for musculoskeletal disorders.

1 reference

7 January 2021

The outcome of surgical treatments for primary Dupuytren's disease--a systematic review.

1 reference

7 January 2021

The efficacy and safety of fasciectomy and fasciotomy for Dupuytren's contracture in European patients: a structured review of published studies

1 reference

7 January 2021

Recognition, diagnosis and referral of patients with Dupuytren's disease: a review of current concepts for general practitioners in Europe

1 reference

7 January 2021

Dupuytren's contracture: a retrospective database analysis to assess clinical management and costs in England.

1 reference

7 January 2021

Multiple concurrent collagenase clostridium histolyticum injections to Dupuytren's cords: an exploratory study

1 reference

7 January 2021

50 years experience with Dupuytren's contracture in the Erlangen University Hospital--a retrospective analysis of 2919 operated hands from 1956 to 2006.

1 reference

7 January 2021

Assessment of clinical severity in Dupuytren's disease

1 reference

7 January 2021

Clostridium histolyticum collagenase in the treatment of Dupuytren's contracture

1 reference

7 January 2021

Does a 'firebreak' full-thickness skin graft prevent recurrence after surgery for Dupuytren's contracture?: a prospective, randomised trial

1 reference

7 January 2021

Cost-effectiveness in the management of Dupuytren's contracture. A Canadian cost-utility analysis of current and future management strategies

1 reference

7 January 2021

Management of Dupuytren's disease--clear advice for an elusive condition

1 reference

7 January 2021

Dupuytren disease: Anatomy, pathology, presentation, and treatment

1 reference

7 January 2021

The emerging role of Clostridium histolyticum collagenase in the treatment of Dupuytren disease.

1 reference

7 January 2021

Eliciting health state utilities for Dupuytren's contracture using a discrete choice experiment

1 reference

7 January 2021

Efficacy of collagenase in patients who did and did not have previous hand surgery for Dupuytren's contracture

1 reference

7 January 2021